Cost-Effectiveness of Late Endovascular Thrombectomy vs. Best Medical Management in a Clinical Trial Setting and Real-World Setting.
Johanna Maria OspelCharlotte ZernaEmma HarrisonTimothy J KleinigVolker PuetzDaniel P O KaiserBrett GrahamAmy Ying Xin YuBrian van AdelJai J ShankarRyan A McTaggartVitor PereiraDonald F FreiWolfgang G KunzMayank GoyalMichael D HillPublished in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2024)
EVT for LVO-patients presenting beyond 6 hours was cost effective in the clinical trial setting and "real-world" setting, although this was largely related to baseline patient differences favoring the "real-world" EVT group. After adjusting for these, EVT benefit was reduced in the trial setting, and absent in the real-world setting.